NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director

Go back to NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director
(NASDAQ: NRXP) Delayed: 2.89 -0.01 (0.34%)
Previous Close $2.90    52 Week High $ 
Open $2.88    52 Week Low $ 
Day High $2.90    P/E N/A 
Day Low $2.81    EPS $ 
Volume 651,706